BMI-1 Autoantibody in Serum as a New Potential Biomarker of Nasopharyngeal Carcinoma

Cancer Biology and Therapy - United States
doi 10.4161/cbt.7.3.5422
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Identification of Serum Amyloid a Protein as a Potentially Useful Biomarker for Nasopharyngeal Carcinoma

Clinical Cancer Research
Cancer ResearchOncology
2004English

Serum Anti-Eif3a Autoantibody as a Potential Diagnostic Marker for Hepatocellular Carcinoma

Scientific Reports
Multidisciplinary
2019English

Predictive Value of miR-9 as a Potential Biomarker for Nasopharyngeal Carcinoma Metastasis

British Journal of Cancer
Cancer ResearchOncology
2013English

Serum Big Endothelin-1 as a Biomarker in Oral Squamous Cell Carcinoma Patients: An Analytical Study

Journal of Applied Oral Science
MedicineDentistry
2015English

5‑Hydroxymethylcytosine as a Potential Epigenetic Biomarker in Papillary Thyroid Carcinoma

Oncology Letters
Cancer ResearchOncology
2019English

Cystatin B as a Potential Diagnostic Biomarker in Ovarian Clear Cell Carcinoma

International Journal of Oncology
Cancer ResearchOncology
2015English

Serum Long Noncoding RNA LRB1 as a Potential Biomarker for Predicting the Diagnosis and Prognosis of Human Hepatocellular Carcinoma

Oncology Letters
Cancer ResearchOncology
2018English

MicroRNAs Serving as Potential Biomarkers and Therapeutic Targets in Nasopharyngeal Carcinoma: A Critical Review

Critical Reviews in Oncology/Hematology
GerontologyGeriatricsHematologyOncology
2016English

Serum Autoantibody Measurement for the Detection of Hepatocellular Carcinoma

PLoS ONE
Multidisciplinary
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy